StockNews.AI
INO
StockNews.AI
160 days

INOVIO to Report Fourth Quarter and Year End 2024 Financial Results on March 18, 2025

1. INOVIO announces Q4 2024 financial results release on March 18, 2025. 2. A live conference call will follow the results discussion at 4:30 p.m. ET. 3. Webcast will include a Q&A session and be archived for 90 days.

4m saved
Insight
Article

FAQ

Why Neutral?

Financial results announcements often have modest effects unless significant surprises occur. Given no details on expected performance, market reactions could be subdued unless results vary greatly from projections.

How important is it?

The earnings report could provide insights into INO's ongoing performance, impacting investor sentiment depending on results.

Why Short Term?

The announcement may affect stock price shortly after the event, but longer-term impacts depend on actual financial performance and strategic developments.

Related Companies

, /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancers, and infectious diseases, today announced that fourth quarter and year-end 2024 financial results will be released after the market close on March 18, 2025. Following the release, INOVIO will host a live conference call and webcast at 4:30 p.m. ET to discuss financial results and provide a general business update. The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event. About INOVIOINOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancers, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com. ContactsMedia: Jennie Willson, (267) 429-8567, [email protected]Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, [email protected]  SOURCE INOVIO Pharmaceuticals, Inc. WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM? 440k+ Newsrooms & Influencers 9k+ Digital Media Outlets 270k+ Journalists Opted In

Related News